Psychiatry & Neurology Doctors in Rocky Mount, NC Accepting Medicare

8 Psychiatry & Neurology doctors found. Showing 1 - 8

Rosario Guarino, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 901 N Winstead Ave, Rocky Mount, NC 27804 Phone: 252-937-0200    Fax: 252-443-0096

Dr. Thomas Swartzwelder, D.O Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 500 Nash Medical Arts Mall, Rocky Mount, NC 27804 Phone: 252-937-8141    Fax: 252-443-9574

Dr. Rita-kay Mabine Davis, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 300 N Grace St, Rocky Mount, NC 27804 Phone: 252-210-9856    Fax: 252-822-5067

Aurora K Pajeau, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 901 N Winstead Ave, Rocky Mount, NC 27804 Phone: 252-937-0200    Fax: 252-937-0240

Dr. Matthew Michael Musulin, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 901 N Winstead Ave, Rocky Mount, NC 27804 Phone: 252-937-0289    Fax: 252-937-3114

William R Deans, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 901 N Winstead Ave, Rocky Mount, NC 27804 Phone: 252-937-0289    Fax: 252-937-3114

Lubica Fedor, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 112 N Circle Dr, Rocky Mount, NC 27804 Phone: 252-443-5451    Fax: 252-442-4312

Scott Mcclelland, DO Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 114 Forest Hill Ave, Suite 2, Rocky Mount, NC 27804 Phone: 252-628-8300    Fax: 252-642-6622

News Archive

Treatment can effectively improve quality of life for people with hyperhidrosis

At least 15 million people in the U.S. experience diminished quality of life due to excessive sweating, or hyperhidrosis.

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.

Newly discovered protein may help explain tuberculosis' resiliency

Weill Cornell scientists have located a protein produced by the tuberculosis bacterium that may tell researchers more about how the invader lives so resiliently inside of the body.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Australian dementia sufferers may wear tracking devices

The Australian Federal Government is said to be considering using electronic wrist tags on people with dementia; the tracking bracelets would be a way of monitoring those suffering from Alzheimer's disease.

Read more Medical News

› Verified 7 days ago